AU2002307635A1 - Methods and means for producing proteins with predetermined post-translational modifications - Google Patents

Methods and means for producing proteins with predetermined post-translational modifications

Info

Publication number
AU2002307635A1
AU2002307635A1 AU2002307635A AU2002307635A AU2002307635A1 AU 2002307635 A1 AU2002307635 A1 AU 2002307635A1 AU 2002307635 A AU2002307635 A AU 2002307635A AU 2002307635 A AU2002307635 A AU 2002307635A AU 2002307635 A1 AU2002307635 A1 AU 2002307635A1
Authority
AU
Australia
Prior art keywords
methods
translational modifications
predetermined post
producing proteins
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2002307635A
Inventor
Abraham Bout
Ronald Hendrik Peter Brus
Johan Christiaan Kapteyn
Dirk Jan Elbertus Opstelten
Petrus Christianus Johannes Josephus Passier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Vaccines and Prevention BV
Original Assignee
Crucell Holand BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crucell Holand BV filed Critical Crucell Holand BV
Publication of AU2002307635A1 publication Critical patent/AU2002307635A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2002307635A 2002-04-19 2002-04-19 Methods and means for producing proteins with predetermined post-translational modifications Withdrawn AU2002307635A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NL2002/000257 WO2003089468A1 (en) 2002-04-19 2002-04-19 Methods and means for producing proteins with predetermined post-translational modifications

Publications (1)

Publication Number Publication Date
AU2002307635A1 true AU2002307635A1 (en) 2003-11-03

Family

ID=29244882

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002307635A Withdrawn AU2002307635A1 (en) 2002-04-19 2002-04-19 Methods and means for producing proteins with predetermined post-translational modifications

Country Status (2)

Country Link
AU (1) AU2002307635A1 (en)
WO (1) WO2003089468A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108888755A (en) * 2018-07-11 2018-11-27 温州医科大学 The new application of erythropoietin(EPO)
CN110760476B (en) * 2019-09-03 2020-11-03 广州瑞臻再生医学科技有限公司 Preparation method of cerebral cortex neural stem cells and glutamatergic neurons

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856298A (en) * 1989-10-13 1999-01-05 Amgen Inc. Erythropoietin isoforms
EA004766B1 (en) * 1999-04-13 2004-08-26 Дзе Кеннет С. Уоррен Инститьют, Инк. Modulation of excitable tissue function by peripherally administered erythropoietin
ES2237420T5 (en) * 1999-04-15 2010-03-03 Crucell Holland B.V. RECOMBINANT PROTEIN PRODUCTION IN A HUMAN CELL.

Also Published As

Publication number Publication date
WO2003089468A1 (en) 2003-10-30

Similar Documents

Publication Publication Date Title
AU2003210890A1 (en) Controlled lighting methods and apparatus
AU2003265190A1 (en) Methods and systems for improved boundary contrast
AU2003266317A1 (en) Al-Cu-Mg-Si ALLOY AND METHOD FOR PRODUCING THE SAME
AU2003240233A1 (en) Method and arrangement for producing radiation
AU2003228269A1 (en) Phosphorylated proteins and uses related thereto
AU2002368286A1 (en) Cellular structure with internal limiting member and method for making the cellular structure
AU2003289742A1 (en) Stable therapeutic proteins
AU2003243660A1 (en) Coordinating flooring and methods
AU2003289551A1 (en) Method and system for manufacturing bulb
AU2002359078A1 (en) Disasemble resin and the manufacturing method for thereof
AU2003226899A1 (en) Human diabetes-mediating proteins
AU2003272423A1 (en) Centrosome proteins and uses thereof
AU2003227861A1 (en) Protein involved in cancer
AU2003215592A1 (en) Lightweight construction element and method for producing the same
AU2002224199A1 (en) Methods and means for producing proteins with predetermined post-translational modifications
AU2003238178A1 (en) Pancreas-specific proteins
AU2002307635A1 (en) Methods and means for producing proteins with predetermined post-translational modifications
AU2003256584A1 (en) Modified proteins stabilized in a desired conformation and methods for producing same
AU2003264075A1 (en) Active fusion proteins and method for the production thereof
AU2003202694A1 (en) Torero protein
AU2003236374A1 (en) Atopic dermatitis-inducing proteins
AU2002368320A1 (en) Mold design method and system
AU2003270055A1 (en) Neurotransmission-associated proteins
AU2003278718A1 (en) Stars-a muscle-specification-binding protein
HK1062924A1 (en) Methods and means for producing proteins with predetermined post- translational modifications

Legal Events

Date Code Title Description
MK13 Application withdrawn section 141(2)/reg 8.3(2) - pct appl. non-entering nat. phase, withdrawn by applicant